Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
8. October 2020

Video: Panel discussion on healthcare digitalization at Forbes Technology 2020

Martin Herman, our co-founder and CEO at Powerful Medical and Martin Smatana (Chief Business Officer of Medannot) have participated in the Forbes Technology 2020 panel discussion on Healthcare Digitalization, where they discussed data, AI, and the products we are bringing to market. They explain how Powerful Medical aids doctors in the diagnosis and treatment of cardiovascular diseases using an AI-powered clinical assistant and how its subsidiary Medannot automates diagnostics and annotation in 3D radiology imaging.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

Doctor holding Roche cobas® pulse point-of-care device displaying PMcardio AI-powered ECG interpretation for real-time heart attack detection at the patient bedside.

PMcardio Expands Heart Attack Detection to Patient Bedside through Roche cobas® pulse Point of Care Platform

Powerful Medical has partnered with Roche to integrate AI-powered ECG interpretation from PMcardio into the cobas® pulse point-of-care platform. Combined with Roche’s Elecsys® high-sensitivity cardiac Troponin T assay, this solution enables clinicians to rapidly and accurately rule in or rule out heart attacks directly at the patient’s bedside.
Smartphone showing This Week in Cardiology podcast episode featuring PMcardio Queen of Hearts™ AI outperforming physicians in ECG interpretation

AI vs MD ECG-Reading for Cath Lab Activation (This Week in Cardiology, by Dr. John Mandrola)

In this episode of This Week in Cardiology, Dr. John Mandrola reviews a study comparing physicians with PMcardio’s Queen of Hearts™ AI. The results show the AI achieved 89% accuracy in detecting subtle STEMI equivalents—far surpassing doctors’ 66%—highlighting its potential to transform early heart attack triage.

Join over 100,000 healthcare professionals who are already taking advantage of AI